Our company news

We are pleased to share the latest updates from Smooth Drug Development for November 2024.

We are pleased to share the latest updates from Smooth Drug Development for October 2024.

At Smooth Drug Development, we are excited to share the latest updates and achievements from September 2024

We are working on the following new projects: We were awarded a contract for medical writing services by a global pharmaceutical company.

We are working on the following new projects: We are starting a phase I Pertuzumab trial.

We are working on the following new projects: Smooth started synopsis preparation services with Benzidamine+Cetylpyridinium chloride.

We are working on the following new projects: A phase 3 clinical trial of Nimesulide Gel 2% was awarded to SDD.

We are working on the following new projects: Semaglutide trial was awarded to SDD.

We are working on the following new projects: • We received a contract for a phase I study with Pembrolizumab.

We are working on the following new projects: • A contract for a phase III study with Aflibercept was signed.

January We are working on the following new projects: • We have successfully passed quality control of a global company and we are finalizing a contract for data management activities in observational programs.

We are working on the following new projects: • We signed a contract for a phase III trial in patients with nasopharyngitis.

We are working on the following new projects: • We won a bidding for an adalimumab trial, phase I.

October We are working on the following new projects: • We signed a contract for medical writing activities for a phase III trial with glucosamine + chondroitin sulfate.

We are working on the following new projects: • We signed a contract for medical writing activities for a BE trial with our long-term Client.